Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Anti-edema effect of melatonin on spinal cord injury in rats

X. Liu, Y. Wang, J. Yang, Y. Liu, D. Zhou, M. Hou, L. Xiang

. 2015 ; 159 (2) : 220-226. [pub] 20150424

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17006063

AIM: To determine the anti-edema effects of melatonin on spinal cord injury (SCI) in rats. METHODS: A total of 150 adult male Sprague-Dawley rats were randomly allocated to the following three groups (n=50): a sham group which underwent laminectomy without dural compression; an SCI group, which underwent laminectomy followed by SCI and received saline i.p. immediately after injury and then daily for 2 days; an MT group, which underwent laminectomy followed by SCI and received a 100 mg/kg dose of melatonin i.p. immediately after SCI and then daily for 2 days. The cords were removed at 12, 24, 48 and 72 h after surgery in every group. Spinal cord edema was evaluated by determining the spinal cord water content. Expressions of AQP4 and GFAP positive cells in injured spinal cord were detected by immunohistochemical staining, and protein expressions of AQP4 and GFAP were detected by Western blotting. RESULTS: Spinal cord water content was obviously increased after SCI, which was maintained almost unchanged by melatonin treatment (100 mg/kg) at 12 h after injury but was significantly reduced from 24 h to 72 h. The expressions of AQP4 and GFAP increased in the injured spinal cord segments, which were decreased by melatonin treatment (100 mg/kg) between 24 h and 72 h after SCI. CONCLUSIONS: Melatonin (100 mg/kg) had anti-edema effects after acute SCI probably by down-regulating the expression level of AQP4 protein, and it may eliminate astrocytic swelling after SCI through down-regulating the expression level of GFAP protein.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17006063
003      
CZ-PrNML
005      
20170308085055.0
007      
ta
008      
170210s2015 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2015.012 $2 doi
035    __
$a (PubMed)25916278
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Liu, Xinwei $u Department of Orthopedics, General Hospital of Shenyang Military Area Command of Chinese PLA, Rescue Center of Severe Wound and Trauma of Chinese PLA, Shenyang, China
245    10
$a Anti-edema effect of melatonin on spinal cord injury in rats / $c X. Liu, Y. Wang, J. Yang, Y. Liu, D. Zhou, M. Hou, L. Xiang
520    9_
$a AIM: To determine the anti-edema effects of melatonin on spinal cord injury (SCI) in rats. METHODS: A total of 150 adult male Sprague-Dawley rats were randomly allocated to the following three groups (n=50): a sham group which underwent laminectomy without dural compression; an SCI group, which underwent laminectomy followed by SCI and received saline i.p. immediately after injury and then daily for 2 days; an MT group, which underwent laminectomy followed by SCI and received a 100 mg/kg dose of melatonin i.p. immediately after SCI and then daily for 2 days. The cords were removed at 12, 24, 48 and 72 h after surgery in every group. Spinal cord edema was evaluated by determining the spinal cord water content. Expressions of AQP4 and GFAP positive cells in injured spinal cord were detected by immunohistochemical staining, and protein expressions of AQP4 and GFAP were detected by Western blotting. RESULTS: Spinal cord water content was obviously increased after SCI, which was maintained almost unchanged by melatonin treatment (100 mg/kg) at 12 h after injury but was significantly reduced from 24 h to 72 h. The expressions of AQP4 and GFAP increased in the injured spinal cord segments, which were decreased by melatonin treatment (100 mg/kg) between 24 h and 72 h after SCI. CONCLUSIONS: Melatonin (100 mg/kg) had anti-edema effects after acute SCI probably by down-regulating the expression level of AQP4 protein, and it may eliminate astrocytic swelling after SCI through down-regulating the expression level of GFAP protein.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x aplikace a dávkování $x farmakologie $7 D000975
650    _2
$a akvaporin 4 $x metabolismus $7 D051401
650    _2
$a tělesná voda $x metabolismus $7 D001834
650    _2
$a down regulace $7 D015536
650    _2
$a edém $x prevence a kontrola $7 D004487
650    _2
$a gliový fibrilární kyselý protein $x metabolismus $7 D005904
650    _2
$a laminektomie $7 D007796
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melatonin $x aplikace a dávkování $x farmakologie $7 D008550
650    _2
$a náhodné rozdělení $7 D011897
650    _2
$a potkani Sprague-Dawley $7 D017207
650    _2
$a mícha $x chemie $x metabolismus $7 D013116
650    _2
$a poranění míchy $x komplikace $7 D013119
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wang, Yu $u Department of Orthopedics, General Hospital of Shenyang Military Area Command of Chinese PLA, Rescue Center of Severe Wound and Trauma of Chinese PLA, Shenyang, China
700    1_
$a Yang, Jishun $u The Medical Department, No. 100 Hospital of Chinese PLA, Suzhou, China
700    1_
$a Liu, Yunen $u Department of Emergency, General Hospital of Shenyang Military Area Command of Chinese PLA, Rescue Center of Severe Wound and Trauma of Chinese PLA, Shenyang, China
700    1_
$a Zhou, Dapeng $u Department of Orthopedics, General Hospital of Shenyang Military Area Command of Chinese PLA, Rescue Center of Severe Wound and Trauma of Chinese PLA, Shenyang, China
700    1_
$a Hou, Mingxiao $u Department of Emergency, General Hospital of Shenyang Military Area Command of Chinese PLA, Rescue Center of Severe Wound and Trauma of Chinese PLA, Shenyang, China
700    1_
$a Xiang, Liangbi $u Department of Orthopedics, General Hospital of Shenyang Military Area Command of Chinese PLA, Rescue Center of Severe Wound and Trauma of Chinese PLA, Shenyang, China
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 2 (2015), s. 220-226
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170210 $b ABA008
991    __
$a 20170224103225 $b ABA008
999    __
$a ok $b bmc $g 1192588 $s 966710
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 159 $c 2 $d 220-226 $e 20150424 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20170210

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...